2 Patents
- US125595462026Methods of Identifying HIV Patients Sensitive to Therapy with Gp120 CD4 Binding Site-directed Antibodies
Gilead Sciences, Inc.
0 cites - US121026772024Methods of Identifying HIV Patients Sensitive to Therapy with GP120 V3 Glycan-directed Antibodies
GILEAD SCIENCES, Inc.
0 cites